ABIM

JUNE 24, 2025

Gertz, MD, MACP, Chair, ABIM Hematology Board The Hematology Board , which meets twice a year and is responsible for oversight of ABIM policy and assessment in the specialty, held its spring meeting on May 2, 2025. A representative from the American Society of Hematology (ASH) joined for a portion of the meeting*.

Board-Certified 40

Board-Certified Board-Certified Physicians Government Community 40

ABIM

JUNE 11, 2025

Some members of the Specialty Board were interested in the LKA experience, participant survey results—particularly responses about fairness—and how LKA performance data might reflect on clinical outcomes. ABIM’s website features expansive sections on research related to assessment and clinical outcomes.

Board-Certified 52

Board-Certified Government Community Education 52

FDA Law Blog

JULY 7, 2024

The guidance restates the central premise of the final rule, i.e., that LDTs are medical devices and the clinical laboratories that design, manufacture and use them to test patient specimens are manufacturers. However, the guidance provides no new information on how FDA expects laboratories to implement these new requirements.

Manufacturing 64

Manufacturing Provider Physicals Electronics 64

ABIM

MAY 30, 2025

The questionnaire gathers information about clinical work and practice patterns, and ABIM uses the information to inform operations, such as updating exam blueprints, developing policies for initial certification and MOC, and ensuring adequately diverse representation of the profession in research and governance.

Board-Certified 40

Board-Certified Government Internal Medicine Private Practice 40

GeriPal

APRIL 3, 2025

I will always, as always, say, you know, you’re welcome to do this in 2026. Annie 02:31 So if you go to the A G S meeting every year, you know that this group of three individuals comprises the AGS literature update. So this is something. This is the plenary to attend. It is a sold out crowd. Of course. We will step aside. Go Cubs, go.

IT 64

IT Hospital Screening Patients 64

FDA Law Blog

JUNE 14, 2023

In the ever-changing landscape of medical device development, FDA is touting steps it is taking that it says will enhance efficiency, foster innovation, and address key challenges faced by developers. Given Dr. Shuren’s propensity to use the phrase, we have yet to see it formally defined by CDRH.

Manufacturing 45

Manufacturing Medical Appointment Patient-Centered 45

FDA Law Blog

FEBRUARY 20, 2025

On February 19, 2025, Judge Sean Jordan in the Eastern District of Texas heard oral arguments in American Clinical Laboratory Association (ACLA) and the Association for Molecular Pathologys (AMP) [1] lawsuit against the Department of Health and Human Services. Mullen & Jeffrey N. It did not. ACLA, of course, confirmed that was true.

Patient-Centered 102

Patient-Centered Consulting Government Clinic 102

Physician's Weekly

JUNE 26, 2025

His clinical study was ending. The HHS budget proposal for fiscal year 2026 makes no mention of vaccine safety programs. He recommended Dressen take steroids and antibodies — treatments that saved her life, she said. And then, according to emails reviewed by KFF Health News, Nath said he couldn’t help anymore. Kennedy Jr.

Vaccination 52

Vaccination Patient-Centered Government IT 52

Physician's Weekly

JUNE 26, 2025

Gavin Newsom has asked lawmakers to push the implementation date to January 2026, leaving patients, insurers, and employers in limbo. Newsom spokesperson Elana Ross said the state needs more time to provide guidance to insurers on specific services not addressed in the law to ensure adequate and uniform coverage.

Insurance 52

Insurance Patient-Centered Provider Management 52

FDA Law Blog

SEPTEMBER 13, 2021

A final OIG rule to change the structure of manufacturer rebates to Medicare Part D and Medicaid Managed Care plans and their PBMs is enmeshed in litigation and is likely to be at least postponed until 2026 (see our post ), and perhaps prevented from implementation altogether, by Congressional mandate. Last Thursday, the U.S.

Manufacturing 98

Manufacturing Supply Chain Patient-Centered Utilities 98